Pauling David 4
4 · SUTRO BIOPHARMA, INC. · Filed Oct 16, 2025
Insider Transaction Report
Form 4
Pauling David
Chief Admin. Ofcr. & GC
Transactions
- Purchase
Common Stock
2025-10-15$0.80/sh+12,504$9,993→ 71,737 total
Footnotes (1)
- [F1]The reported total includes 2,500 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c).